Legal Representation
Attorney
Aaron D. Hendelman
USPTO Deadlines
Next Deadline
1752 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-05-21)
Due Date
May 21, 2030
Grace Period Ends
November 21, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 21, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 21, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 18, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 17, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Apr 9, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Apr 8, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 19, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 19, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 17, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 22, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 22, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 2, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 17, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 14, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 13, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 13, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 10, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 10, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 10, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 28, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 6, 2022 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 5, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 22, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Therapeutic pharmaceuticals in the nature of oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Anywhere:
20230300
First Use in Commerce:
20230300
Class 042
Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology
First Use Anywhere:
20230300
First Use in Commerce:
20230300
Additional Information
Design Mark
The mark consists of the 44 text inside of a partially full circle a top of a boat with 2 parallel wavy lines with one longer than the other at the bottom of the boat.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
FORTY FOUR; FOUR FOUR
Classification
International Classes
005
042